We are live on
!
Find out more
ECSS
Eurizon Capital SGR SpA Portfolio holdings
AUM
$37.3B
This Fund
S&P 500
This Quarter
Est. Return
-2.13%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$32B
AUM Growth
-$117M
(-0.36%)
Cap. Flow
+$1.57B
Cap. Flow
% of AUM
4.89%
Top 10 Holdings %
Top 10 Hldgs %
33.58%
Holding
1,302
New
212
Increased
446
Reduced
365
Closed
109
Avg Time Held
0.8
quarters
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$378M |
| 2 |
Walmart Inc
WMT
|
+$273M |
| 3 |
NXP Semiconductors
NXPI
|
+$221M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$195M |
| 5 |
Johnson Controls International
JCI
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$223M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$182M |
| 3 |
Verizon
VZ
|
+$168M |
| 4 |
Freeport-McMoran
FCX
|
+$119M |
| 5 |
Amazon
AMZN
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.67% |
| 2 | Financials | 11.07% |
| 3 | Consumer Discretionary | 10.91% |
| 4 | Healthcare | 10.33% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SF
726
Stifel
SF
$10.7B
| $232K | ﹤0.01% |
3,202
-1,418
| -31% | -$113K |
2025 Q4
1 quarter
|
|
727
Madrigal Pharmaceuticals
MDGL
$11.4B
| $231K | ﹤0.01% |
455
-274
| -38% | -$131K |
2025 Q4
1 quarter
|
|
728
First Horizon
FHN
$11.1B
| $230K | ﹤0.01% |
10,368
-9,966
| -49% | -$238K |
2025 Q4
1 quarter
|
|
729
Onto Innovation
ONTO
$16B
| $228K | ﹤0.01% |
1,155
+102
| +10% | +$20.9K |
2025 Q4
1 quarter
|
|
730
Guardant Health
GH
$24.7B
| $228K | ﹤0.01% |
2,630
+397
| +18% | +$39.9K |
2025 Q4
1 quarter
|
|
731
Eldorado Gold
EGO
$9.76B
| $228K | ﹤0.01% |
6,997
| – | – |
2025 Q4
1 quarter
|
|
732
Nicolet Bankshares
NIC
$3.47B
| $227K | ﹤0.01% |
1,555
+1,488
| +2,221% | +$216K |
2025 Q4
1 quarter
|
|
733
Tenet Healthcare
THC
$21.2B
| $226K | ﹤0.01% |
1,198
-752
| -39% | -$158K |
2025 Q4
1 quarter
|
|
734
Unum
UNM
$14.3B
| $226K | ﹤0.01% |
3,080
-1,400
| -31% | -$104K |
2025 Q4
1 quarter
|
|
735
Assurant
AIZ
$13.2B
| $225K | ﹤0.01% |
1,036
-48
| -4% | -$10.9K |
2025 Q4
1 quarter
|
|
736
StoneCo
STNE
$2.69B
| $224K | ﹤0.01% |
+15,834
| New | +$243K |
2026 Q1
0 quarters
|
|
737
Service Corp International
SCI
$10.5B
| $223K | ﹤0.01% |
2,717
+579
| +27% | +$46.7K |
2025 Q4
1 quarter
|
|
|
NBIS
738
Nebius Group N.V.
NBIS
$63.1B
| $220K | ﹤0.01% |
+4,345
| New | +$434K |
2026 Q1
0 quarters
|
|
739
EastGroup Properties
EGP
$10.6B
| $214K | ﹤0.01% |
1,158
+261
| +29% | +$48.8K |
2025 Q4
1 quarter
|
|
740
OGE Energy
OGE
$9.35B
| $212K | ﹤0.01% |
4,404
+208
| +5% | +$9.52K |
2025 Q4
1 quarter
|
|
741
Chemed
CHE
$6.65B
| $210K | ﹤0.01% |
558
| – | – |
2025 Q4
1 quarter
|
|
742
Hecla Mining
HL
$11.5B
| $208K | ﹤0.01% |
12,022
+10,422
| +651% | +$235K |
2025 Q4
1 quarter
|
|
743
Penumbra
PEN
$12.5B
| $205K | ﹤0.01% |
622
+97
| +18% | +$32.8K |
2025 Q4
1 quarter
|
|
744
BridgeBio Pharma
BBIO
$13B
| $205K | ﹤0.01% |
2,938
+2,353
| +402% | +$171K |
2025 Q4
1 quarter
|
|
745
Legend Biotech
LEGN
$3.61B
| $202K | ﹤0.01% |
11,165
-2,451
| -18% | -$46.7K |
2025 Q4
1 quarter
|
|
746
UGI
UGI
$7.94B
| $195K | ﹤0.01% |
5,285
+262
| +5% | +$9.86K |
2025 Q4
1 quarter
|
|
|
WBS
747
DELISTED
Webster Financial
WBS
| $193K | ﹤0.01% |
+2,829
| New | +$194K |
2026 Q1
0 quarters
|
|
748
Magnachip Semiconductor
MX
$128M
| $192K | ﹤0.01% |
70,944
+2,769
| +4% | +$7.89K |
2025 Q4
1 quarter
|
|
749
Baidu
BIDU
$29.5B
| $192K | ﹤0.01% |
1,726
-2,876
| -62% | -$390K |
2025 Q4
1 quarter
|
|
750
Primerica
PRI
$8.61B
| $190K | ﹤0.01% |
766
+106
| +16% | +$27.3K |
2025 Q4
1 quarter
|
|
Similar funds
PIF
TWC
Eurizon Capital SGR SpA's Q1 2026 Portfolio in Review
As of Q1 2026, Eurizon Capital SGR SpA held 1,302 positions worth $32B, down 0.36% from $32.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Eurizon Capital SGR SpA deployed $1.57B of net new capital in Q1 2026, opening 212 new positions and adding to 446 existing holdings. Its largest new stake was Visa: 1,176,374 shares worth $355M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $223M trimmed.
- Eurizon Capital SGR SpA's largest Q1 2026 buy was Visa: 1,176,374 shares worth $355M.
- Eurizon Capital SGR SpA added most to Fifth Third Bancorp in Q1 2026, an estimated $195M increase.
- Eurizon Capital SGR SpA's biggest Q1 2026 reduction was Apple, cutting an estimated $223M.
- Eurizon Capital SGR SpA fully exited HDFC Bank in Q1 2026, selling an estimated $5.5M.
- Eurizon Capital SGR SpA's ten largest holdings make up 34% of its $32B portfolio in Q1 2026.
- Eurizon Capital SGR SpA opened 212 new positions and closed 109 in Q1 2026.
- Eurizon Capital SGR SpA's portfolio value fell 0.36% quarter-over-quarter to $32B.
Based on Eurizon Capital SGR SpA's 13F filing for Q1 2026, filed 8 May 2026.